Back to search
FDAFDA · Food and drugs·Recall number D-0378-2019

EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01

Published January 23, 2019 · Recall initiated: April 17, 2017

Summary

FDA records drug Class II recall D-0378-2019, published January 23, 2019 and initiated April 17, 2017. Recalling firm: Syntho Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 5,000 bottles; Lot: Lot #: S16E02, Exp 05/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Syntho Pharmaceuticals, Inc.
Distributor
Product was sold to the firm's sole distributor who further distributed the product throughout the United States.
Lot
Lot #: S16E02, Exp 05/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01 recalled?

Yes. FDA published recall D-0378-2019 on January 23, 2019. Reported hazard: CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

What should I do if I have this product?

Voluntary: Firm initiated · Letter